References
- Dabbs D. J., Striker L. M-M., Mignon F., Striker G. Glomerular lesions in lymphomas and leukaemias. The American Journal of Medicine 1986; 80: 63–70
- Russman B. S., Melchrbit R., Dtennan J C. Spinal muscular atrophy: the natural course of the disease. Muscle Nerve 1983; 6: 119–191
- Velasquez W. S., Cabanillas F., Salvador P., McLaughlin P., Fridrik M., Ticker S., Jagannath S., Hagemeister K. B., Redman J. R., Swan F., Barlogie B. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP). Blood 1988; 71: 117–122
- Horning S. J., Chao N. J., Negrin R. S., Hoppe R. T., Long G. D., Hy W. W., Wong R. M., Brown B. W., Blume K G. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic factors. Blood 1997; 89: 801–813
- Alpers C. E., Cotran R S. Neoplasia and glomerular injury. Kidney International 1986; 30: 465–473
- Shapiro C. M., Vander Laan B. F., Jao W., Sloan D E. Nephrotic syndrome in two patients with cured Hodgkin's disease. Cancer 1985; 55: 1799–1804
- Fer M. F., McKinney T. D., Richardson R. L., Hande K. R., Oldham R. K., Greco F A. Cancer and the kidney: renal complications of neoplasms. The American Journal of Medicine 1981; 71: 704–718
- Cavalli F. Rare syndromes in Hodgkin's disease. Annals of Oncology 1998; 9(suppl. 5)S109–S113
- Stéphan J. L., Deschenes G., Pérel Y., Bader-Meunier B., Brunat-Mentigny M., Lejars O., Lamagnères I P. Nephrotic syndrome and Hodgkin disease in children: a report of five cases. European Journal of Pediatrics 1997; 156: 239–242
- Fouque D., Laville M., Colon S., French M., Berger F., Labeeuw M., Zech P. Cyclosporin A-sensitive nephrotic syndrome preceding Hodgkin's disease by 32 months. Clinical Nephrology 1990; 34: 1–4
- Walker F., O'Neill S., Carmody M., O'Dwyer W F. Nephrotic syndrome in Hodgkin's disease. The International Journal of Pediatric Nephrology 1983; 4: 39–41
- Delmez J. A., Safdar S. H., Kissane J M. The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkins disease. American Journal of Kidney Diseases 1994; 23: 743–746
- Moorthy A. V., Zimmerman S. W., Burkholder P M. Nephrotic syndrome in Hodgkin's disease: evidence for pathogenesis alternative to immune complex deposition. The American Journal of Medicine 1976; 61: 471–477
- Poppema S., Potters M., Emmens R., Visser L., van den Berg A. Immune reactions in classical Hodgkin's lymphoma. Seminars in Hematology 1999; 36: 253–259
- Mori T., Yabuhara A., Nakayama J., Kitahara M., Washizawa K., Kasai S., Komiyama A. Frequently relapsing minimal change nephrotic syndrome with natural killer cell deficiency prior to the overt relapse of Hodgkin's disease. Pediatric Nephrology 1995; 9: 619–620
- Gruss H. J., Herrmann F., Drexler H G. Hodgkin's disease: a cytokine-producing tumor-a review. Critical Reviews in Oncogenesis 1994; 5: 473–538
- Seymour J. F., Kurzrock R. Interleukin-6: biologic properties and role in lymphoproliferative disorders. Molecular Genetics and Therapy of Leukemia, E. J. Freireich, H. Kantarjian. Kluwer, Boston 1996; 167–206
- Seymour J. F., Talpaz M., Hagemeister F. B., Cabanillas F., Kurzrock R. Clinical correlates of elevated serum levels of interleukin-6 in patients with untreated Hodgkin's disease. American Journal of Medicine 1997; 102: 21–28
- Fattori E., Delia Rocca C., Costa P., Giogio M., Dente B., Pozzi L., Ciliberto G. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 1994; 83: 2570–2579
- Eagen J. W., Lewis E J. Glomerulopathies of neoplasia. Kidney International 1977; 11: 297–306
- Lorich J. K., Glovanek E. G., Moloney W C. Nephrosis of Hodgkin's Disease. Archives of Internal Medicine 1973; 132: 597–600
- Gordon P. H., Rowland L. P., Younger D. S., Sherman W. H., Hays A. P., Louis E. D., Lange D. J., Trojaborg W., Lovelace R. E., Murphy P L., Latov N. Lymphoproliferative disorders and motor neuron disease: an update. Neurology 1997; 48: 1671–1678
- Katsume A., Miyai T., Suzuki H., Moriguchi Y., Kawata H., Tatsumi T., Suematsu S., Kishimoto T., Ohsugi Y. Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice. Clinical Immunology and Immunopathology 1997; 82: 117–124